Cardioprotective and hypolipidemic effects of nisoldipine in the JCR:LA- cp rat

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 5, 1997, Pages 586-592

  Russell, James C ^a   Dolphin, Peter J ^b   Graham, Sandra E ^a   Amy, Roger M ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Atherosclerosis; Calcium channel antagonists; Hypertriglyceridemia; JCR:LA cp rat; Myocardial lesions

Indexed keywords

ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL ESTER; GLUCOSE; INSULIN; NISOLDIPINE; NITRIC OXIDE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; HYPOLIPEMIA; INSULIN RESISTANCE; MALE; NONHUMAN; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; VASODILATATION;

ANIMALS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; DILTIAZEM; FEMALE; LIPIDS; MALE; MICROSCOPY, ELECTRON, SCANNING; MYOCARDIAL CONTRACTION; MYOCARDIUM; NIFEDIPINE; NISOLDIPINE; RATS; RATS, INBRED STRAINS; SEX CHARACTERISTICS; TIME FACTORS;

EID: 0030960457     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199705000-00004     Document Type: Article

References (32)

1. Koletsky S. Obese spontaneously hypertensive rats: a model for the study of atherosclerosis. Exp Mol Pathol 1973;19:53-60.
2. Koletsky S. Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 1975;80:129-42.
3. Hansen CT, Michaelis OE, eds. New models of genetically obese rats for studies in diabetes, heart disease, and complications of obesity. Bethesda: National Institutes of Health, 1988.
4. Russell JC, Amy RM, Manickavel V, Ahuja SK, Rajotte RV. Insulin resistance and impaired glucose tolerance in the atherosclerosis prone LA/N-corpulent rat. Arteriosclerosis 1987;7:620-6.
5. Dolphin PJ, Stewart B, Amy RM, Russell JC. Serum lipids and lipoproteins in the atherosclerosis prone LA/N-corpulent rat. Biochim Biophys Acta 1987;919:140-8.
6. Russell JC, Koeslag DG, Amy RM, Dolphin PJ. Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats. Arteriosclerosis 1989;9:869-76.
7. Vance JE, Russell JC. Hypersecretion of VLDL, but not HDL, by hepatocytes from the JCR:LA-corpulent rat. J Lipid Res 1990;31: 1491-501.
8. Russell JC, Graham S, Hameed M. Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat. Metabolism 1994;43: 538-43.
9. Pederson RA, Campos RV, Buchan AMJ, Chisholm CB, Russell JC, Brown JC. Comparison of the enteroinsular axis in two strains of obese rats: the fatty Zucker and JCR:LA-corpulent. Int J Obesity 1991;15:461-70.
10. Chan CB, MacPhail RM, Kibenge MT, Russell JC. Increased glucose phosphorylating activity correlates with insulin secreting capacity of male JCR:LA-corpulent rat islets. Can J Physiol Pharmacol 1995;73:501-8.
11. Russell JC, Amy RM. Plasma lipids and other factors in the LA/N-corpulent rat in the presence of chronic exercise and food restriction. Can J Physiol Pharmacol 1986;64:750-6.
12. Russell JC, Amy RM. Myocardial and vascular lesions in the LA/N-corpulent rat. Can J Physiol Pharmacol 1986;64:1272-80.
13. Russell JC, Amy RM. Early atherosclerotic lesions in a susceptible rat model, the LA/N-corpulent rat. Atherosclerosis 1986;60:119-29.
14. Russell JC, Amy RM, Michaelis OE, McCune SM, Abraham AA. Myocardial disease in the corpulent strains of rats. In: Shafrir E, ed. Frontiers in diabetes research: lessons from animal diabetes III. London: Smith-Gordon, 1990:402-7.
15. Amy RM, Dolphin PJ, Pederson RA, Russell JC. Comparison of myocardial disease in two strains of obese rats: the fatty Zucker and LA/N-corpulent. Atherosclerosis 1988;69:199-209.
16. McNamee CJ, Kappagoda CT, Kunjara R, Russell JC. Defective endothelium-dependent relaxation in the JCR:LA-corpulent rat. Circ Res 1994;74:1126-32.
17. Russell JC, Koeslag DG, Dolphin PJ, Amy RM. Prevention of myocardial lesions in JCR:LA-corpulent rats by nifedipine. Arteriosclerosis 1990;10:658-64.
18. Russell JC, Amy RM, Koeslag DG, Dolphin PJ. Independence of myocardial disease in the JCR:LA-corpulent rat of plasma cholesterol concentration. Clin Invest Med 1991;14:288-95.
19. Russell JC, Graham S, Stewart B, Dolphin PJ. Sexual dimorphism in the metabolic response to the calcium channel antagonists, diltiazem and clentiazem, by hyperlipidemic JCR:LA-cp rats. Biochim Biophys Acta 1995;1258:199-205.
20. Poiley SM. A systematic method of breeder rotation for non-inbred laboratory animal colonies. Anim Care Panel 1960;10:159-61.
21. Russell JC, Amy RM, Graham SE, Dolphin PJ, Wood GO, Bar-Tana J. Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by β,β′-tetramethylhexadecanedioic acid (MEDICA 16). Arterioscler Thromb Vasc Biol 1995;15:918-23.
22. Kuksis A, Myher JJ, Geher K, et al. Comparative determination of plasma cholesterol and triacylglycerol levels by automated gas-liquid chromatographic and autoanalyzer methods. J Chromatogr 1978;146:393-412.
23. Bailey NTJ. Statistical methods in biology. Cambridge. UK: Cambridge University Press, 1981.
24. DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoid curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978;235: E97-102.
25. Sugawara H, Tubise K, Onodera S. Absence of antioxidant effects of nifedipine and diltiazem on myocardial membrane lipid peroxidation in contrast with those of nisoldipine and propranolol. Biochem Pharmacol 1994;47:877-92.
26. Kramsch DM, Sharma RC. Limits of lipid-lowering therapy: the benefits of amlodipine as an antiatherosclerotic agent. J Hum Hypertens 1995;9(suppl 1):53-9.
27. Naylor WG. The antiatherogenic effects of amlodipine: promise of preclinical data. J Hum Hypertens 1992;6(suppl 1):S19-23.
28. Meyer P, Lang MG, Flammer J, Luscher TF. Effects of calcium channel blockers on the response to endothelin-1. bradykinin and sodium nitroprusside in porcine ciliary arteries. Exp Eye Res 1995;60:505-10.
29. Russell JC, Amy RM, Graham S, Wenzel LM, Dolphin PJ. Effect of castration on hyperlipidemic, insulin resistant JCR:LA-corpulent rats. Atherosclerosis 1993;100:113-22.
30. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-31.
31. Opie LH, Messerli FH. Nifedipine and mortality: grave defects in the dossier. Circulation 1995;92:1068-73.
32. Kloner RA. Nifedipine in ischemic heart disease. Circulation 1995;92:1074-78.